Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry

Bibliographic Details
Main Authors: R. van Westrhenen, M. Ingelman-Sundberg
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.725565/full
_version_ 1819133495552770048
author R. van Westrhenen
R. van Westrhenen
R. van Westrhenen
M. Ingelman-Sundberg
author_facet R. van Westrhenen
R. van Westrhenen
R. van Westrhenen
M. Ingelman-Sundberg
author_sort R. van Westrhenen
collection DOAJ
first_indexed 2024-12-22T09:48:12Z
format Article
id doaj.art-dc4e32a4090c4c4b9b26c3e9eeea29bc
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-22T09:48:12Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-dc4e32a4090c4c4b9b26c3e9eeea29bc2022-12-21T18:30:29ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-09-011210.3389/fphar.2021.725565725565Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in PsychiatryR. van Westrhenen0R. van Westrhenen1R. van Westrhenen2M. Ingelman-Sundberg3Parnassia Psychiatric Institute, Amsterdam, NetherlandsDepartment of Psychiatry and Neuropsychology, Maastricht University, Maastricht, NetherlandsInstitute of Psychiatry, Psychology and Neuroscience (IoPPN) Kings College, London, United KingdomDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Swedenhttps://www.frontiersin.org/articles/10.3389/fphar.2021.725565/fullpharmacogenomicspsychiatrypsychopharmacologyCYP enzymesside effects
spellingShingle R. van Westrhenen
R. van Westrhenen
R. van Westrhenen
M. Ingelman-Sundberg
Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
Frontiers in Pharmacology
pharmacogenomics
psychiatry
psychopharmacology
CYP enzymes
side effects
title Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
title_full Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
title_fullStr Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
title_full_unstemmed Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
title_short Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
title_sort editorial from trial and error to individualised pharmacogenomics based pharmacotherapy in psychiatry
topic pharmacogenomics
psychiatry
psychopharmacology
CYP enzymes
side effects
url https://www.frontiersin.org/articles/10.3389/fphar.2021.725565/full
work_keys_str_mv AT rvanwestrhenen editorialfromtrialanderrortoindividualisedpharmacogenomicsbasedpharmacotherapyinpsychiatry
AT rvanwestrhenen editorialfromtrialanderrortoindividualisedpharmacogenomicsbasedpharmacotherapyinpsychiatry
AT rvanwestrhenen editorialfromtrialanderrortoindividualisedpharmacogenomicsbasedpharmacotherapyinpsychiatry
AT mingelmansundberg editorialfromtrialanderrortoindividualisedpharmacogenomicsbasedpharmacotherapyinpsychiatry